ARK Genomic Revolution ETF vs Box Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.89, while Box Inc trades at $28.92 (market cap $3.97B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Box Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BOX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $33.55 |
52-Week Low | $23.09 | $21.37 |
Market Cap | — | $3.97B |
Enterprise Value | — | $4.52B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BOX trades at $28.64, down 0.56% today, with strong analyst support (17 Buy, 10 Hold, 1 Sell) and a $37.00 consensus price target representing 29% upside. The company shows robust revenue growth from $874M in 2022 to $1.09B in 2025, with net income surging to $244.62M. Recent expansion of Box Zones in Switzerland, Israel, and Singapore (Business Wire, June 30, 2026) enhances global data governance capabilities. Technical indicators show bullish moving averages but overbought RSI levels.
BOX presents a compelling growth story with expanding profitability and strategic international expansion, though elevated valuation multiples (P/E 44.75) require continued execution. Key risks include competitive cloud storage pressures and debt levels, while institutional sentiment remains positive with significant upside to price targets.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →